RSS-Feed abonnieren
DOI: 10.1055/a-1429-3039
Hope for new developments in the reimbursement of oncological PET/CT in Germany
Hoffnung auf neue Entwicklungen bei der Erstattung onkologischer PET/CT-Indikationen in Deutschland![](https://www.thieme-connect.de/media/10.1055-s-00034924/202103/lookinside/thumbnails/nuk-1179_10-1055-a-1429-3039-1.jpg)
In Germany, health technology assessment (HTA) of new examination and treatment methods (“Neue Untersuchungs- und Behandlungsmethoden”, NUBs) like PET by the Joint Federal Committee (“Gemeinsamer Bundesausschuss”, G-BA) follows strict regulations from the Social Code Part V (“Sozialgesetzbuch Teil V”, SGB V). For the coverage of medical procedures by German statutory health insurances (“Gesetzliche Krankenversicherung”, GKV), a distinction is essentially made between outpatient and inpatient care sectors as well as a third sector of health care in Germany, the so-called outpatient specialist care (“Ambulante Spezialfachärztliche Versorgung”, ASV) according to § 116b SGB V.
Publikationsverlauf
Artikel online veröffentlicht:
09. Juni 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany